These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 14509983)

  • 1. [Individualized treatment of respiratory infection should be emphasized].
    Wang ZL
    Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):365-6; discussion 366. PubMed ID: 14509983
    [No Abstract]   [Full Text] [Related]  

  • 2. Community-acquired bacterial respiratory tract infections.
    Brunton S; Carmichael B; Fitzgerald M; Liu H; Varon J; Weiland D
    J Fam Pract; 2005 Mar; 54(3):255-62. PubMed ID: 15755379
    [No Abstract]   [Full Text] [Related]  

  • 3. The continuing challenge of lower respiratory tract infections.
    Moellering RC
    Clin Infect Dis; 2004 May; 38 Suppl 4():S319-21. PubMed ID: 15127364
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the resistance of bacterial agents of respiratory tract infections].
    Roester U
    Med Welt; 1966 Sep; 39():2080-3. PubMed ID: 5920478
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resistance of infectious agents involved in low respiratory tract infections in France].
    Varon E; Houssaye S
    Med Mal Infect; 2006; 36(11-12):555-69. PubMed ID: 16962730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Refractory respiratory tract infections. 9. Chemotherapy of recent respiratory tract infections. a. Branhamella catarrhalis infection].
    Nagatake T; Rikitomi N; Tao M; Watanabe K; Mbaki N; Matsumoto K
    Nihon Rinsho; 1987 Mar; 45(3):604-10. PubMed ID: 3599486
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
    Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
    Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
    [No Abstract]   [Full Text] [Related]  

  • 8. Barriers to the effective management of respiratory tract infections in the community.
    Saginur R
    Infection; 2001 Dec; 29 Suppl 2():3-10. PubMed ID: 11785853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamic study of antibiotic resistance of bacterial environment of the ENT department].
    Pal'chun VT; Kafarskaia LI; Poliakova TS; Gurov AV
    Vestn Otorinolaringol; 2004; (1):53-6. PubMed ID: 15029126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infections.
    Nicolau DP
    Am J Manag Care; 2004 Oct; 10(12 Suppl):S381-8. PubMed ID: 15603247
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial drug use and resistance among respiratory pathogens in the community.
    Low DE
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S206-13. PubMed ID: 11524720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rising to the challenge of resistance: a case study-based discussion.
    Housset B
    Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S11-6. PubMed ID: 17307651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing pattern of chest infection.
    Venkatesan P
    Practitioner; 1995 Mar; 239(1548):183-6. PubMed ID: 7708625
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
    Fuller JD; Low DE
    Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel agents for the treatment of outpatient respiratory tract infections. Introduction.
    Pell DM
    Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592
    [No Abstract]   [Full Text] [Related]  

  • 16. Information from your family doctor. Antibiotics: when they can and can't help.
    American Academy of Family Physicians
    Am Fam Physician; 2006 Oct; 74(7):1188. PubMed ID: 17039758
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thoughts on the problem of testing germ resistance preceding antibiotic therapy of bacterial-inflammatory disorders of the respiratory tract].
    Gregori P
    Dtsch Gesundheitsw; 1966 Aug; 21(32):1517-20. PubMed ID: 5923478
    [No Abstract]   [Full Text] [Related]  

  • 18. The evolution of antimicrobial agents used for the management of CARTIs: a focus on a new class of antimicrobials--the ketolides.
    Sbarbaro JA
    Am J Manag Care; 2004 Oct; 10(12 Suppl):S389-99. PubMed ID: 15603248
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan.
    Hsueh PR; Shyr JM; Wu JJ
    Clin Infect Dis; 2005 Mar; 40(6):903-5. PubMed ID: 15736030
    [No Abstract]   [Full Text] [Related]  

  • 20. [Variations of microbial sensitivity in lower respiratory tract infections].
    Aguerre MM; Costa de Mello B
    Hoja Tisiol; 1971; 28(1-2):41-76. PubMed ID: 5173683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.